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Abstract
Objective: We examined the inhibition of stimulus-stimulus associations (formally ‘conditioned inhibition’) in Tourette syndrome
(TS). Method: The present study used video game style conditioned inhibition procedures suitable for children and adolescents.
We tested 15 participants with a clinical diagnosis of TS in the absence of co-morbid attention deficit hyperactivity disorder and
compared them with 19 typically developing age and sex matched controls (both groups aged 10–20 years). All children were
tested for inhibition by summation test using two test stimuli in each of two conditioned inhibition tasks. Results: TS participants
showed overall normal inhibition of stimulus-stimulus associations, and there was no correlation between inhibitory learning
scores and symptom severity ratings. However, there was a clear reduction in conditioned inhibition in 7 TS participants
medicated with clonidine. There was no significant effect of medication on excitatory learning of the stimulus-stimulus
associations. Conclusions: We suggest that clonidine’s effect on inhibitory as opposed to excitatory learning could be related to
reduced noradrenergic activity. In terms of clinical implications for TS, impaired conditioned inhibition could reduce the ability of
susceptible individuals to learn to control tics in the presence of associative triggers.
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Résumé
Objectif: étudier l’inhibition dans les associations stimulus-stimulus (officiellement appelées inhibitions conditionnées) chez les
sujets atteints du syndrome Gilles de la Tourette (SGT). Méthodologie: analyse des contrôles inhibiteurs au moyen de jeux
vidéos adaptés à des enfants et à des adolescents. Quinze sujets ayant reçu un diagnostic de SGT sans comorbidité de TDAH
ont été comparés à 19 témoins ne présentant aucun retard de développement; les sujets, qui étaient appariés selon l’âge et le
sexe, avaient entre 10 et 20 ans. Un test d’inhibition sommaire a été administré à tous les enfants; chaque tâche axée sur
l’inhibition conditionnée faisait appel à deux stimuli. Résultats: l’inhibition globale des associations stimulus-stimulus était
normale chez les sujets Tourette; il n’y avait aucune corrélation entre les notes d’apprentissage des contrôles inhibiteurs et les
notes de sévérité des symptômes. Toutefois, on a constaté une nette baisse des contrôles inhibiteurs chez sept sujets Tourette
qui prenaient de la clonidine. La médication n’avait aucun effet significatif sur l’apprentissage des contrôles excitateurs dans les
associations stimulus-stimulus. Conclusion: l’effet opposé de la clonidine entre l’apprentissage des contrôles inhibiteurs et
l’apprentissage des contrôles excitateurs pourrait, selon nous, être lié à une réduction de l’activité noradrénergique. Au niveau
clinique, le manque d’inhibition conditionnée pourrait limiter la capacité des sujets à apprendre par association à maitriser leurs
tics en présence d’événements déclencheurs.
Mots clés: syndrome de Tourette, apprentissage par association, inhibition conditionnée, clonidine
Abbreviations: CI = conditioned inhibitor; CS = conditioned stimulus; CSt = transfer stimulus; Sg = generalized stimulus;
TS = Tourette syndrome; UCS = unconditioned stimulus; YGTSS = Yale Global Tic Severity Scale.
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Introduction
Tourette syndrome (TS) is a developmental disorder char-acterized by involuntary, repetitive, stereotypic tics, both
motor and vocal (Albin and Mink, 2006, Chowdhury, 2008,
Jankovic, 2001, Leckman, 2003, Robertson, 2000, 2006,
Sheppard et al., 1999, Spencer et al., 1998, Swerdlow, 2001,
The Tourette Syndrome Classification Study Group, 1993).
Based on the presenting symptoms, inhibitory deficits are
thought to be fundamental to TS (Brand et al., 2002, Comings
and Comings, 1987, Georgiou et al., 1995, Gilbert et al.,
2004, Sheppard et al., 1999, Swerdlow et al., 1996). Accord-
ingly, inhibitory processes have been a focus of experimental
studies of TS. However, the majority of investigations into
cognitive and behavioral processes in TS have failed to dem-
onstrate any significant differences compared to matched
controls in participants without co-morbid attention deficit
hyperactivity disorder. For example, participants with TS
have been reported to perform as normal on Go/NoGo mea-
sures of response inhibition (Roessner et al., 2008, Serrien et
al., 2005). Similarly, unless the inhibitory demands of the
experimental task are increased, TS participants show no sig-
nificant performance deficits in the color-word Stroop task or
the flanker task (Channon et al., 2003, 2006, 2009).
Thus the experimental evidence suggests that TS involves
more than simple deficits in response inhibition. Moreover,
when performance on procedural learning tasks was system-
atically compared with that on a task requiring associative
learning (stimulus-stimulus as well as stimulus-response) in
TS, the underlying learning systems were found to be
dissociable (Marsh et al., 2005). Stimulus-stimulus associa-
tions provide a mechanism through which environmental
events can act as symptom triggers and have been suggested
to explain variability in the frequency of symptoms in a range
of disorders (Ferguson and Cassaday, 1999, Lishman, 1987,
Siegel, 1977, Stewart et al., 1984, Watson, 1924). In TS, tics
vary markedly in frequency and severity over the course of a
day (Jankovic, 2001, Leckman, 2003, The Tourette Syn-
drome Classification Study Group, 1993). This variation is
predictable where tics are triggered by certain life situations,
moreover motor and phonetic tics are often preceded by pre-
monitory sensations (such as ‘burning’ of the eye before a eye
blink tic, sore throat preceding grunting), alleviated by the
performance of the tic (Conelea and Woods, 2008; Jankovic,
2001, Leckman, 2003, Leckman et al., 1993, Prado et al.,
2008, The Tourette Syndrome Classification Study Group,
1993). Thus environmental events and premonitory sensa-
tions provide a source of stimuli that could become associated
with tic-generated stimuli through stimulus-stimulus associa-
tions. Such antecedent stimuli have recently been targeted in
behavioral treatments for TS (Conelea and Woods, 2008,
Verdellen et al., 2008, Woods et al., 2009).
An earlier study of ‘latent inhibition’, in which stimulus
pre-exposure should reduce stimulus-stimulus associative
learning, found this effect to be normal in TS participants
(Swerdlow et al., 1996). However, although so-called latent
inhibition procedures retard later learning they do not render
the pre-exposed stimulus truly inhibitory (Baker and Mackin-
tosh, 1977). True inhibition is rather demonstrated by estab-
lishing a stimulus selectively to predict the occasions on
which an otherwise expected outcome will not occur (Pavlov,
1927, Rescorla, 1969). This inhibitory learning is a
well-established phenomenon in the animal literature and is
known to be modulated by the catecholamines (Harmer and
Phillips, 1999; Tobler et al., 2003).
To date, no research has explicitly examined the inhibition of
stimulus-stimulus associations (formally ‘conditioned inhibi-
tion’) in disorders such as TS. In conditioned inhibition pro-
cedures, a conditioned stimulus (CS) is presented
immediately prior to an unconditioned stimulus (UCS),
except on those occasions when it is preceded by the condi-
tioned inhibitor (CI). Thus the CI comes to inhibit the
CS-UCS association. We have developed video game style
conditioning procedures that demonstrate reliable condi-
tioned inhibition and are suitable for younger participants
(Migo et al., 2006). Developmentally, tics typically onset
between the ages of 3 and 8 years, peak early in the teens, and
reduce by the age of 19 or 20 years (Chang et al., 2004,
Chowdhury, 2008, Dooley et al., 1999, Leckman, 2003,
Leckman et al., 1998). In the present study, we therefore
tested conditioned inhibition in children and adolescents with
a clinical diagnosis of TS (in the absence of co-morbid atten-
tion deficit hyperactivity disorder) and typically developing
age and sex matched controls. As discussed above, the experi-
mental evidence for inhibitory deficits in TS is inconsistent.
Nonetheless, based on the evidence that inhibitory deficits are
fundamental to TS, the a priori hypothesis under test in the
present study was that participants with TS would show
impaired inhibition of stimulus-stimulus associations.
Medication is indicated where tics cause significant interfer-
ence with normal daily function, and traditionally, in line with
the established role of the basal ganglia (Cheon et al., 2004,
Giedd et al., 2001, Hyde et al., 1995, Mink, 2001, Minzer et
al., 2004, Peterson et al., 1998, Sheppard et al., 1999, Stern et
al., 2000), dopamine antagonists have been used (Gilbert,
2006; Srour et al., 2008). Moreover, medication (with
neuroleptics) has previously been reported to improve the
learning of stimulus-response associations in experimental
studies of TS (Marsh et al., 2004). However, because of con-
cern over side effects with dopamine antagonists, a variety of
other medications have been used in TS; for example,
clonidine which acts as a noradrenergic alpha-2 agonist
(Srour et al., 2008). This action is of a priori interest given the
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body of evidence to suggest a role for noradrenalin as a key
modulator of behavioural inhibition and anxiety (Gray, 1982;
Nigg, 2000). In the present study, the effects on conditioned




15 TS participants (12 males, 3 females, mean age = 13 years
11 months, range = 10–20 years; Table 1) were recruited for
the current study (The Child and Adolescent Clinic, Psychia-
try Department, Queen’s Medical Centre, Nottingham). All
met DSM IV criteria for TS in the absence of comorbid
ADHD. TS participants were also assessed using the Yale
Global Tic Severity Scale (YGTSS) within 2 months of test-
ing in the present study (same day scores were available for
11/15 participants). Diagnoses were made by a consultant
psychiatrist (CP) and qualified members of his team. Addi-
tional assessments were conducted by a research nurse. The
available IQ scores (for n=12 TS participants) had been mea-
sured using the Wechsler Abbreviated Scale of Intelligence
(vocabulary and matrix subscales).
With respect to medication at the time of testing, seven TS
participants were on clonidine (25–100 mcg), one was on
clonazepam (500 mcg), one was on the atypical antipsychotic
aripiprazole, three had previously been on clonidine but had
been medication free for a minimum of 4 months prior to the
study (doses 50-200 mcg), one was drug free that day (previ-
ously treated with aripiprazole), and two had never received
any medication for their TS symptoms (Table 1).
Of 35 potential controls tested, 19 were selected to provide
the best match for age (within 6 months as measured on the
day of testing) and sex with the TS participants. This yielded a
control sample of 15 males and 4 females (mean age = 13
years 5 months, range = 10–20 years). None of the controls
had family members with TS. In addition, they were screened
using the Strengths and Difficulties Questionnaire (copyright
Robert Goodman, 2005; Goodman, 1997). Although some
difficulties were rated ‘somewhat true’ in the matched control
participants there were no abnormal scores indicative of any
undiagnosed illness; similarly, the matched controls were not
on any psychotropic medication for TS, or for any other con-
dition.
This study was approved by NHS Research Ethics
(Derbyshire REC, reference 08/H0401/34, approved April
2008). All participants received an inconvenience allowance
of £5-£10 to cover their travel expenses. Written consent was
obtained from participants over the age of 16, both parents
J Can Acad Child Adolesc Psychiatry, 20:2, May 201198
Kantini et al
Table 1 Demographics, medication and symptom scores for the TS participants.
Subjects Age (months) Sex
Medication YGTSS
Type Dosage (mcg) Motor Phonic Impairment Total score
TS-1 137 Male Clonazepam 500 14 13 25 52
TS-2 209 Male (Aripiprazole) 2.5* n/a n/a n/a 66
TS-3 176 Female Clonidine 25-50 0 0 0 0
TS-4 151 Male (Never) n/a 5 0 0 5
TS-5 151 Male (Clonidine) 50* 5 0 0 5
TS-6 163 Male Clonidine 100 11 0 20 31
TS-7 161 Female Clonidine 75-100 11 10 15 36
TS-8 193 Male Clonidine 50 9 9 0 18
TS-9 197 Male (Clonidine) 200* 7 2 20 29
TS-10 155 Male Clonidine 50 18 11 10 39
TS-11 127 Male (Never) n/a 12 9 10 31
TS-12 190 Male Clonidine 50 15 14 30 59
TS-13 247 Male Aripiprazole n/a 13 19 15 47
TS-14 121 Male Clonidine 50 5 0 0 5
TS-15 136 Female (Clonidine) n/a* 14 14 10 38
TS = Tourette Syndrome participant code; mcg = micrograms medication dosage per day; YGTSS = Yale Global Tic Severity Scale; n/a = data not
available or not applicable. *Previous medication dosages; previous medication types indicated in brackets (i.e. participant was not under any
medication at test); never = never medicated for TS.
and children signed the consent forms where participants
were under 16 years.
Materials
The task programs were produced in E-studio and utilized
E-prime (Psychology Software Tools Inc., Pittsburgh, USA)
to present the stimuli to the participants (Figure 1). The pro-
grams were run on personal computers with 17” monitors or
on a portable 15” laptop computer when travel to the partici-
pant was required for testing.
Procedure
Conditioned inhibition task 1: Mission-to-Mars
The task scenario was based on a hypothetical mission to
Mars. Participants were informed that they were to play the
role of a commander of a fleet of starships travelling on an
exploration mission to Mars; on the course of their mission,
spaceships in the fleet are prone to explode. During the train-
ing phase there were no explicit learning instructions, partici-
pants were simply asked to carefully count the number of
surviving rockets. There were 9 cycles of the 5 stimulus
sequences shown in Table 2, presented in a random order. On
inhibited trials, a 1-second gray frame surrounding a blue
screen was presented. This was the CI. On excitatory trials,
there was a 1-second presentation of an empty blue screen (at
the equivalent point in the stimulus sequence). Next the CS (a
large planet) was followed by 3 distractors (smaller planets)
appearing and disappearing on the same screen, for a com-
bined total of 4 seconds, then the UCS (i.e. rocket presenta-
tion) on excitatory trials or absence of the UCS (i.e. exploded
rocket presentation) on inhibited trials. Participants were
required to click the mouse to continue.
The subsequent test phase consisted of 20 further trials. There
were 5 cycles of the 4 stimulus sequences shown in Table 2,
presented in a random order. The procedure for test trials was
identical to that used in training, except that prior to the pre-
sentation of the US or its absence, participants were presented
with an on-screen rating, scaled 1-9. At this point, they were
required to estimate the likelihood of the spaceship surviving
versus exploding, with a rating of 9 to represent the highest
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Figure 1. The stimuli presented during (1) Mission-to-Mars and (2) Weapon-X task.
CSa and CSb = trained conditioned stimuli, also presented together with the inhibitor during training; CSt = transfer conditioned stimulus, not trained with the
inhibitor; Sg = generalized stimulus, not introduced at training, new at test; US = unconditioned stimulus.
likelihood, and a rating of 1 to represent the lowest likelihood
of survival. An intermediate rating of 5 represented uncer-
tainty. Ratings were made by clicking in the appropriate on
screen box using the mouse.
This was a summation test of conditioned inhibition. Partici-
pants’ ratings provided a measure of the inhibitory properties
of the CI using two kinds of test stimuli: (1) generalized (Sg
from the same category but not introduced at training); and
(2) transfer (CSt familiar from training but not previously pre-
sented with the CI).
Conditioned inhibition task 2: Weapon-X
This task was presented with a scenario based on the
Weapon-X comic book story. Participants were informed that
they were to play the role of Professor Thorton, Director of
the Weapon-X project, with the job to create the ultimate liv-
ing weapon, using metallurgic skeletal bonding to convert
Logan into Wolverine. Failure results in the feral mutation of
Logan. Participants were further informed that in order to
learn Thorton’s secret, they were to carefully observe his
work in order to work out the causes of success (Wolverine)
versus failure (the feral mutation).
As for the previous task, the training phase consisted of 45
learning trials, presented as 9 cycles of the 5 stimulus
sequences shown in Table 2. However, in the Weapon-X task,
3 stimuli appeared simultaneously: the CI or its absence (rep-
resented by an injector syringe), the CS (a block of a certain
fictitious alloy), and a distractor (presented as a type of radia-
tion), for a total of 4 seconds on screen. These images were
followed by a 1-second presentation of an image of Logan in
the midst of the attempted transformation, then the presenta-
tion of the US or its absence. The success or failure of the
metallurgical bonding was represented by an image of Wol-
verine as the UCS, or a picture of feral Logan representing the
absence of the UCS (Figure 1). Participants were required to
click the mouse to continue. As above, the testing phase con-
sisted of 20 further trials with the key Sg and CSt summation
test presentations. The procedure for test trials was identical
to that used in training, except that prior to the presentation of
the US or its absence, participants were presented with an
on-screen rating, scaled 1-9, with a rating of 9 to represent the
highest likelihood of success, as in task 1.
Design and Analysis
Analysis of variance (ANOVA) was run in a mixed design
with up to four within-subjects factors to assess the develop-
ment of conditioned inhibition: inhibition (the presence or
absence of the CI); task (Mission-to-Mars versus
Weapon-X); stimulus type (Sg vs. CSt); presentation, of
which there were five levels.
Diagnosis and medication were between subjects factors,
examined in successive analyses. The effect of diagnosis was
examined overall. The effect of medication was examined
within the TS group. The on-medication participants were
under treatment with clonidine (n=7) or clonazepam (n=1) at
the time of behavioural testing. An off-clonidine group (n=7)
were not under treatment with clonidine or clonazepam at the
time of behavioural testing, but this group included one par-
ticipant under treatment with aripiprazole (which has a differ-
ent mechanism of action, discussed below). Analyses were
collapsed across task, stimulus type and presentation where
these factors did not affect the development of conditioned
inhibition. Planned comparisons (t-tests at p=0.05) were con-
ducted to examine effects of a priori interest.
The dependent variable to assess conditioned inhibition in the
factorial analyses (and shown in Figures 2-3) was the partici-
pants’ raw expectancy scores (for appearances of an intact
rocket in task 1 or the successful transformation of Logan into
Wolverine in task 2). In addition, a conditioned inhibition
ratio was calculated by dividing the average expectancy score
for non-inhibited stimulus presentations by the average
expectancy score for inhibited stimulus presentations. Thus
conditioned inhibition is indicated by a ratio greater than one
and the absence of conditioned inhibition by a ratio less than
or equal to one. Thus this derived variable provided a single
summary inhibition score per participant, adjusted for the
expectancy of the non-inhibited stimulus, which was used in
correlational analyses. Specifically, the interrelationship
between the level of conditioned inhibition summarized by
the ratio and symptom severity scores (measured by the
YGTSS) was explored by Pearson’s r correlation (the total
YGTSS scores were available for all participants; the
subscale scores were available for all but one participant).
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Table 2 The stimulus combinations presented
during the training and testing phase of the two
tasks
Training phase Testing phase
CSa+ CSt+
[CI, CSa]- [CI, CSt]-
CSb+ Sg+
[CI, CSb]- [CI, Sg]-
CSt+
Example stimuli are shown in Figure 1. CSa and CSb = trained condi-
tioned stimuli, also presented together with the inhibitor during training;
CI = conditioned inhibitor; CSt = transfer conditioned stimulus, not trained
with the inhibitor; Sg = generalized stimulus, not introduced at training,
new at test; ‘+’ indicates the presentation of the US (i.e. an intact rocket
for the Mission-to-Mars and a picture of Wolverine for the Weapon-X
task); ‘-’ indicates the absence of the US (represented as an exploded
rocket for the Mission-to-Mars and a picture of feral Logan for the
Weapon-X task).
Where the data were available (for 12/15 TS participants), the
same analyses were repeated to examine conditioned inhibi-
tion performance on each of the tasks in relation to TS partici-
pants’ IQ. Similarly, the effect of medication was further
examined by correlational analysis, using both the raw dura-
tion and a ratio to adjust for participants’ age (length of time
on medication divided by the age of the participant).
Results
There was a main effect of inhibition (F1,32=28.184,
p<0.001). Figure 2A shows that the TS participants demon-
strated an overall equivalent level of inhibition to the matched
controls, and this was confirmed statistically in that there was
no significant interaction between the diagnosis and inhibi-
tion (F1,32=0.079, p=0.781). Figure 2B shows that perfor-
mance was equivalent in the two task variants, and
statistically there were no significant interactions involving
task and inhibition (F1,32=1.439, p=0.239). Similarly, there
were no effects of stimulus type (Sg vs. CSt) or presentation
with respect to inhibition (F1,32=3.725, p=0.063).
Figure 3 shows that conditioned inhibition was reduced by
medication in the TS sample. This impression is confirmed
statistically by a significant interaction between medication
and inhibition (F1,13=5.881, p<0.05). Exclusion of the single
participant on clonazepam from the on-medication group,
primarily composed of participants on clonidine, does not
change this conclusion in that the interaction between medi-
cation and inhibition remained significant (F1,12=5.359,
p<0.05). The participant on clonazepam is therefore included
with the participants on clonidine for the subsequent
analyses.
Conditioned inhibition (shown as the difference between
non-inhibited and inhibited response scores) was clearly
demonstrated in TS participants in the off-clonidine group
(t6=4.626, p<0.01, Cohen’s d=3.62). By contrast, condi-
tioned inhibition was absent in TS participants who were on
medication at the time of testing (t7=1.323, p=0.228). Further
planned comparisons confirm that the reduction in condi-
tioned inhibition arose primarily because of a relatively large
effect of medication in the inhibited condition (t13=3.061,
p<0.01, Cohen’s d=1.7). There was no significant difference
in excitatory learning measured in the non-inhibited condi-
tions in relation to medication status (t13=1.82, p=0.092).
The Mission-to-Mars task was implicit, and procedures were
equivalent as far as possible, so learning was not measured
during the training phases. Therefore, in order to assess the
level to which learning had occurred in the different groups,
the data from the first test presentation of the non-inhibited
CSt (which was used during training phase) were analysed.
Univariate analysis of the first test presentation showed no
overall significant difference between the TS groups (on- or
off-clonidine) and the matched controls (F2,31=1.999,
p=0.153). Neither was there any difference by task:
Weapon-X task (F2,31=0.498, p=0.612); Mission-to-Mars
task (F2,31=1.437, p=0.253).
Possible confounds
There was no correlation between symptom severity mea-
sured by the YGTSS overall and performance on either of the
conditioned inhibition tasks as summarized by the condi-
tioned inhibition ratios (maximum r14=0.241, p=0.388).
There were similarly no significant correlations between con-
ditioned inhibition performance and the level of phonic
symptoms (maximum r14=0.315, p=0.273), motor symptoms
(maximum r14=0.276, p=0.34) or phonic plus motor symp-
toms total score (maximum r14=0.314, p=0.274). There was a
significant relationship between IQ and the Mission-to-Mars
conditioned inhibition ratio (r12=-0.606, p<0.05), but this was
inconsistently demonstrated in that there was no such correla-
tion between IQ and the Weapon-X conditioned inhibition
ratio (r12=-0.350, p=0.264).
For TS participants in the on-medication group, there was no
correlation between performance on the conditioned inhibi-
tion tasks and medication duration (as the raw score or
adjusted for participants’ age; maximum r8=-0.555,
p=0.153). To further address possible confounds of medica-
tion with age (as age may have affected conditioned inhibi-
tion) and/or tic severity (as those TS participants on- or
off-clonidine may have had a different symptom profile),
analyses of covariance were conducted using age and/or
scores of the YGTSS as covariates of medication for the TS
group. It was found that the significant interaction between
inhibition and medication remained intact regardless of the
age (F1,13=5.46, p<0.05) and (total) YGTSS scores of the TS
participants (F1,13=5.501, p<0.05).
However, there were overall sex differences in conditioned
inhibition in the sample of TS participants and their matched
controls. This was demonstrated statistically as a significant
interaction between inhibition and sex (F1,32=7.56, p=0.01)
whereby conditioned inhibition was overall demonstrated by
the male participants (t26=6.157, p<0.001) but not the females
(t6=0.413, p = 0.694). This difference in conditioned inhibi-
tion arose because, compared to the females, the male partici-
pants showed greater level of excitatory learning
(non-inhibited) responses (t32=3.20, p<0.01) as well as
greater inhibition, shown as a lower level of inhibited
responses (t17.84=2.886, p=0.01).
This sex difference might be irrelevant to our overall conclu-
sion in that controls were matched by sex as well as age in
order to examine conditioned inhibition in TS. Moreover,
there were only 3 female participants with TS and 4
age-matched female controls. However, medication status
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Figure 2. The overall effect of inhibition with respect to diagnostic group overall (A) and by each task
variant (B).
Conditioned inhibition was significant in all groups (* = p<0.05, ** = p<0.01, *** = p<0.001). Mean Response refers to the participants ’ expectancy ratings, scaled
1-9, with a rating of 9 to represent the highest likelihood of the outcome (see text for further details) .
2A
2B
was determined by factors outside of our control: one female
was off- whilst two were on-medication. Thus the sex differ-
ence in conditioned inhibition could in principle contribute to
the apparent effect of medication. Accordingly, the key anal-
ysis was also run with the female participants excluded: the
interaction between inhibition and medication remained sig-
nificant, both with (F1,10=7.79, p=0.02) and without
(F1,9=6.40, p<0.05) inclusion of the participant on
clonazepam.
Discussion
The learning of conditioned inhibition was confirmed by the
summation test for conditioned inhibition (Rescorla, 1969),
specifically by the transfer of inhibition to a CS not previ-
ously presented with the CI during training (CSt) and to a
novel stimulus from the same category, to which participants
would generalised their excitatory responding (Sg). Statisti-
cally, there was no difference in the level of conditioned inhi-
bition demonstrated by stimulus type, or task. The
equivalence of results across the two stimulus types shows
that the inhibitory properties of the CIs transferred both to a
stimulus with which it had never previously been experienced
and to a new stimulus with which participants had no explicit
prior training of any kind. The tasks were very different in
terms of content but formally identical with respect to design
and procedure, in all aspects other than the task instructions
and the serial versus simultaneous presentation of the CIs.
That there was no difference in performance by task suggests
that explicit learning instructions are not necessary to show
conditioned inhibition with the kinds of procedure in use and
that the serial versus simultaneous presentation of the CIs was
not an issue.
Counter to prediction, participants with TS showed normal
inhibition of stimulus-stimulus associations. Clinically TS
has long been viewed as a disorder of inhibition yet experi-
mental studies typically find little deficit on tasks thought to
involve inhibitory processes (Channon et al., 2003, 2006,
2009; Roessner et al., 2008). Indeed there is even some evi-
dence of enhanced performance on a saccadic shifting task in
TS (Mueller et al., 2006). Typically measures of inhibitory
(dys)function have used volitional response measures of the
kind Nigg (2000) classifies as effortful, involving conscious
control (see also Channon et al., 2009). Our tasks tap a differ-
ent aspect of inhibitory (dys)function, moreover with no dif-
ference between the explicit and the implicit learning variant,
thus falling within Nigg’s classification of automatic inhibi-
tion. Within this category, other studies, for example of inhi-
bition of return (Yuen et al., 2005) and negative priming
(Ozonoff et al., 1998) have found no evidence for inhibitory
deficits in cases of TS without comorbidity. Thus although
the above ‘automatic’ tasks are very different tasks from the
current one, in that they do not rely heavily on learning, the
overall pattern of outcomes (mixed results from effortful
inhibitory tasks, negative results from more automatic tasks)
is broadly consistent with the outcome of the present study of
participants with TS without comorbidity.
However, when the participants with TS were examined with
respect to their medication, a clear difference was seen in the
level of conditioned inhibition. The majority of the partici-
pants were medicated with clonidine which has some anxio-
lytic properties (typically attributed to reduced sympathetic
activity; Bremner et al., 1996). The participants treated with
aripiprazole (of which only one was currently medicated at
the time of behavioural testing) were categorized as ‘off-med-
ication’ because aripiprazole is an atypical antipsychotic with
a different profile of action, which does reduce noradrenergic
activity. Whilst aripiprazole has recently been reported to
relieve some symptoms of anxiety and depression, this effi-
cacy has only been demonstrated as an adjunctive treatment
in the context of residual symptoms that are resistant to treat-
ment with anti-depressants (Adson et al., 2005, Worthington
et al., 2005) and has been attributed to the drug’s serotonergic
mechanisms of action (Pae et al., 2008). The clonazepam par-
ticipant was included in the on-medication group because of
its anxiolytic properties as a benzodiazepine. Although the
effects of benzodiazepines on the noradrenergic system are
indirect, similar to clonidine, they reduce noradrenergic
activity (Gray, 1982; Bremner et al., 1996). As might be
expected, the peripheral effects of benzodiazepines, for
example their hypotensive properties, are similar to those of
clonidine (Hossmann et al., 1980). In any event, analyses
excluding the participant with clonazepam produced the
same outcome.
From a theoretical perspective, the selective effect on inhibi-
tory as opposed to excitatory learning could be related to
clonidine’s actions on the Behavioural Inhibition System.
According to Gray (1982), reduced noradrenergic activity
should impair the processing of signals of nonreward of the
kind provided by the CIs used in the present study. The gray
frame (task 1) and the injector syringe (task 2) specifically
predicted that the rewarding outcome would not occur (repre-
sented by the alternate outcomes of an exploded rocket in task
1 and feral Logan in task 2). Such processing was clearly
impaired in participants under clonidine. However, the
Behavioural Inhibition System was developed as a theory of
anxiety rather than conditioned inhibition so this account is
only applicable to CIs for rewarding outcomes.
Alternatively, the reduction of sympathetic activity caused by
clonidine may result in the disruption of attentional or learn-
ing processes necessary to task performance. With respect to
learning, we cannot distinguish effects on the acquisition of
the inhibitory association during the training phase from
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effects on the expression of inhibitory learning at test. The
earlier acquisition of the discrimination between inhibited
and non-inhibited stimuli was not directly assessed in the
training phase, because of the implicit nature of the Mis-
sion-to-Mars task instructions. However, for both task vari-
ants, trial 1 responding to the transfer stimulus provided a
measure of the level of excitatory learning, and any differ-
ences between groups, before the introduction of a CI for this
association. Analysis of excitatory conditioning to the trans-
fer stimulus showed no differences between the diagnostic
groups, or by medication in TS participants, in either task.
This lack of difference would seem to rule out any obvious
impairment of the attentional or learning processes necessary
to task performance under clonidine. Nonetheless, the mech-
anism underlying the modification of the conditioned associ-
ation in the ‘inhibited’ condition could be viewed in terms of
attention moderating the salience of the different stimuli. For
example, the medicated group may not have apportioned suf-
ficient attention to the CI in order for the modification of the
conditioned response to occur. It is also possible that there
was a difference in difficulty between the two learning condi-
tions. Rather than inhibiting the excitatory association
directly, the ‘inhibited’ condition could require the formation
of more complex learned associations. This alternative expla-
nation is testable in the sense that, if true, clonidine should
similarly impair learning in configural learning tasks.
In other words, the underlying mechanism(s) for the differ-
ence by drug treatment, and the involvement of inhibition can
only be inferred. However, numerous studies with equivalent
tasks in animals have shown that the conditioned response is
suppressed following concurrent or preceding inhibitory
stimuli (Pavlov, 1927, Rescorla, 1969). This suppression of
conditioned responding is the basis of the summation test
used here. Moreover, although there was no direct measure of
what was occurring at a physiological level in the present
study, dopamine neurons have been found to show opposite
patterns of activity during inhibitory and excitatory condi-
tioning (Tobler et al., 2003).
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Figure 3. The effect of inhibition in relation to medication.
The individual data points show the sex of the participants ( = male, open symbols;  = female, closed symbols) and their medication status. In the ‘off’
group, three participants had formerly been on clonidine and one had formerly been on aripiprazole, one was still on aripiprazole (see text for explanation), two
had never been on any medication. In the on-medication group all of the participants were on clonidine save one who was on clonazepam. Conditioned inhibi-
tion was significant in the off- but not in the on-medication group because of a reduction in inhibitory learning in the on-medication participants
* = p<0.05, ** = p<0.01, *** = p<0.001).
Mean Response refers to the participants’ expectancy ratings, scaled 1-9, with a rating of 9 to represent the highest likelihood of the outcome (see text for
further details).
Conclusions
Through impaired conditioned inhibition, certain medica-
tions for TS could impair potential cognitive control mecha-
nisms for the suppression of tics (via an action on the
associative chain that generates triggers). Specifically,
impaired inhibition of stimulus-stimulus associations could
leave TS sufferers less able to inhibit tics in the presence of
the premonitory urge when cues to inhibit are present in the
environment. Such contextual factors have recently become
the focus of behavioral treatments for TS: through extinction
of the excitatory association (Verdellen et al., 2008); and in
their capacity as discriminative stimuli in relation to tic conse-
quences (e.g., reinforcement for suppression; Woods et al.,
2009). Thus the cognitive side effects of drugs like clonidine
should be taken into account in weighing up the costs and
benefits of treatments of this kind (Srour et al., 2008; Tiplady
et al., 2005). In particular, the present findings point to the
need for specific studies to investigate the moderator effects
of clonidine on the efficacy of behaviour therapies for tics.
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